BALCOM ALEXANDRA (Chief Financial Officer) sold 11.8% of their position (11.43K shares) of NUVALENT, INC. on the open market
Open‑market sale worth $1.41M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Class A Common Stock
Shares
+5.38K
Price / share
$6.89
Trade value
$37.10K
% of position
Class A Common Stock
Shares
+6.05K
Price / share
$18.93
Trade value
$114.45K
% of position
Class A Common Stock
Shares
−11.43K
Price / share
$123.58
Trade value
$1.41M
% of position
Net shares
+0.00
Net value
-$1.26M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 7/1/2026 | M · Option Exercise | +5.38K | $6.89 | $37.10K | 6.3% | 85.53K | 90.92K |
| Class A Common Stock Direct | 7/1/2026 | M · Option Exercise | +6.05K | $18.93 | $114.45K | 6.7% | 90.92K | 96.96K |
| Class A Common Stock Direct | 7/1/2026 | S · Sale | −11.43K | $123.58 | $1.41M | 11.8% | 96.96K | 85.53K |
| Total | +0.00 | -$1.26M | ||||||
Stock Option (Right to Buy)
Class A Common Stock
5.38K shares
Shares
−5.38K
Strike price
6.89
Held after
8.02K
Exercisable
—
Stock Option (Right to Buy)
Class A Common Stock
6.05K shares
Shares
−6.05K
Strike price
18.93
Held after
22.93K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock5.38K shares | 7/1/2026 | M · Option Exercise | −5.38K | 6.89 | — | 8.02K |
| Stock Option (Right to Buy) Direct | Class A Common Stock6.05K shares | 7/1/2026 | M · Option Exercise | −6.05K | 18.93 | — | 22.93K |